Abstract:Liling Chen, 1 Cunqing Zheng, 1 Honglin Luan, 2 Xinyuan Chen 3 1 Department of Clinical Laboratory, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang Province, People's Republic of China; 2 Department of Psychiatry, Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang Province, People's Republic of China; 3 Department of Clinical Laboratory, Wenzhou Central Hospital, Wenzhou, Zhejiang Province, People's Republic of China Correspondence: Xinyuan Chen, Department of Clinical Laboratory, Wenzhou Central Hospital, Bailidonglu Street, Lucheng District, Wenzhou, 325000, People's Republic of China, Tel +8615858805715, Fax +86057788070190, Email Purpose: This study aimed to assess High-density Lipoprotein (HDL)-based Inflammatory Indices and lipid profile changes in antipsychotic-naive first-episode schizophrenia (AN-FES) patients, chronic schizophrenia (CS) patients, and explore the clinical and predictive value of these parameters for schizophrenia. Patients and Methods: The study cohort included 52 AN-FES patients, 46 CS patients, and 52 healthy controls (HCs), with an average age of 24 years. Upon admission, patients underwent complete blood count and lipid profile analyses. Various ratios were calculated, including neutrophil-to-HDL (NHR), monocyte-to-HDL (MHR), lymphocyte-to-HDL (LHR), and platelet-to-HDL (PHR), as well as lipid ratios like triglycerides/HDL, non-HDL/HDL, total cholesterol/HDL, and low-density lipoprotein/HDL. For the AN-FES group, these evaluations were repeated after two months of treatment with atypical antipsychotics. Statistical analyses included correlation analysis, Receiver Operating Characteristic (ROC) curve analysis, and univariate and multivariate regression. Results: Compared to HCs, CS patients exhibited significantly higher MHR and NHR values, while AN-FES patients showed elevated levels of PHR, MHR, and NHR. No significant differences were observed in LHR or lipid ratios across the three groups. In the AN-FES cohort, MHR correlated positively with neutrophil counts, and NHR with monocyte counts. Additionally, white blood cell counts were positively associated with both MHR and NHR. Following treatment, NHR levels decreased, whereas TG/HDL ratios increased, with MHR and PHR remaining elevated. ROC analysis highlighted NHR as the most diagnostically valuable parameter (AUC = 0.799), with 86.5% specificity at an optimal cutoff of 3.534, outperforming MHR and PHR. Regression analyses recognized NHR (OR=2.225) as an independent risk factor for schizophrenia, even after adjusting for confounders. Conclusion: HDL-based inflammatory indices, particularly NHR, may serve as valuable diagnostic and prognostic markers in young adults with schizophrenia, even though significant alterations in lipid ratios were not observed in this demographic. Keywords: neutrophil-to-HDL ratio, NHR, monocyte-to-HDL ratio, MHR, platelet-to-HDL ratio, PHR, lipid ratios, schizophrenia, inflammatory indices Schizophrenia (SCZ) is a severe mental disorder that affects millions of people globally. It is characterized by cognitive disturbances, perceptual anomalies, and emotional blunting. Despite extensive research, the etiology of SCZ remains unclear, involving complex interactions between immune, environmental, and genetic factors. 1,2 Recent studies indicate that inflammation and immune dysfunction, both within the central nervous system and peripheral immune responses, 3,4 along with oxidative stress, play significant roles in the pathophysiology of SCZ. 5,6 Individuals with chronic schizophrenia (CS) or those experiencing their first episode of schizophrenia may exhibit systemic inflammation and disruptions in lipid metabolism. 7–11 Abnormal lipid metabolism may contribute to inflammation in various diseases, 12 highlighting the importance of investigating the relationship between inflammatory and metabolic pathways in SCZ. 13–15 High-density lipoprotein cholesterol (HDL) is a crucial component of the blood lipid profile recognized for its anti-thrombotic, anti-inflammatory, and antioxidant properties, as well as its regulation of activated neutrophil functions. 16–18 Decreased HDL levels were shown to be related to inflammation. 19 Inflammatory responses can cause fluctuations in the levels of neutrophils, monocytes, lymphocytes, and platelets, all of which are easily measured through a complete blood count. 20 Consequently, combined markers derived from peripheral blood cell measures and biochemical assays, such as the neutrophil-to-HDL ratio (NHR), lymphocyte-to-HDL ratio (LHR), monocyte-to-HDL ratio (MHR), and platelet-to-HDL ratio (PHR), are under scrutiny -Abstract Truncated-

Neutrophil–Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic Therapies

The neutrophil-lymphocyte ratio in first-episode medication-naïve patients with schizophrenia: A 12-week longitudinal follow-up study

Evaluation of Relationship of Neutrophil/Lymphocyte, Platelet/Lymphocyte, Monocyte/Lymphocyte Monocyte/HDL Ratios and Systemic Immune Inflammatory Index Value with Antipsychotic Treatments in Schizophrenic Patients

Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study

Neutrophil/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs

The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia

Neutrophil/lymphocyte, Platelet/lymphocyte and Monocyte/lymphocyte Ratios in Schizophrenia

The Associations of Neutrophil-Lymphocyte, Platelet-Lymphocyte, Monocyte-Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia

Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study

Neutrophil/lymphocyte ratio and cognitive performances in first-episode patients with schizophrenia and healthy controls

Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

The relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio, monocyte- lymphocyte ratio and cognitive function in schizophrenia

Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment

Clinical and Diagnostic Value of High-Density Lipoprotein-Based Inflammatory Indices and Lipid Ratios in Young Adults with Schizophrenia

Hematological and inflammatory markers in Han Chinese patients with drug-free schizophrenia: relationship with symptom severity

Lower Plasma CC16, a Natural Anti-Inflammatory Protein, and Increased Plasma Interleukin-1 Receptor Antagonist in Schizophrenia: Effects of Antipsychotic Drugs

Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis

Evaluation of inflammatory markers obtained from complete blood count in different stages of schizophrenia

Lymphocyte level and selected cognitive functions in patients with schizophrenia – preliminary results

Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine

Clinical and imagenologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: A systematic review with meta-analysis